PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $306 | -45.4% | 10 | -28.6% | 0.00% | – |
Q2 2023 | $560 | +25.0% | 14 | +27.3% | 0.00% | – |
Q1 2023 | $448 | – | 11 | – | 0.00% | – |
Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2022 | $1,000 | -98.0% | 15 | -98.3% | 0.00% | -100.0% |
Q2 2022 | $50,000 | -62.7% | 862 | -50.9% | 0.00% | -60.0% |
Q1 2022 | $134,000 | – | 1,756 | – | 0.01% | – |
Q4 2021 | $0 | – | 0 | – | 0.00% | – |
Q3 2021 | $0 | – | 0 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 47 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | +100.0% | 47 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -75.0% | 47 | -50.5% | 0.00% | – |
Q4 2018 | $4,000 | – | 95 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |